Category Archives: Technology

Combating Opioid Abuse With Science

So far, the creative approaches industry has taken to develop tamper-resistant and abuse-deterrent opioid drugs have been largely matched by the ingenuity of those users who manage to tamper with and abuse those same formulations.
Also posted in FDA, R&D, Regulatory, Safety, Strategy | Tagged , , , | 3 Comments

FDA: Steps Toward Quantitative Safety Assessment

A new collaboration will move FDA closer to predicting adverse events – before they happen – as part of the regulatory process In an article published in Nature last June, FDA’s Darrell Abernethy, Lawrence Lesko and Janet Woodcock outlined the agency’s desire to incorporate “mechanism-based drug safety assessment and prediction” into the regulatory approval process. [...]
Also posted in FDA, R&D, Regulatory, Safety | Leave a comment

Unmet Need in the Migraine Space?

Allergan CEO David Pyott is bullish on Botox’s potential as a salve for chronic migraine. He’s also betting on a next-gen dihydroergotamine (DHE) – Levadex – from MAP Pharmaceuticals.
Also posted in FDA, Global, Marketing, Regulatory, Strategy | Tagged , , , , | 2 Comments

Close to Home: Is Good Health Communicable?

The 2011 Edelman Health Barometer suggests that—in the same way that we spread colds, diseases, and other illnesses from person to person—good health and healthy behaviors can also be spread. Can pharma play a pivotal role in the good-health epidemic? Energy. An active lifestyle. Mental and emotional stability. Absence of disease. Nutrition. These are some of [...]
Also posted in healthcare, social media | Tagged , , , | 1 Comment

The Rising Clout of the Patient

by Sarah Krüg In 2011, the patient’s clout as a stakeholder was firmly established, as reflected in several industry conferences. What’s next for the patient in 2012?
Also posted in Events, Meetings, Patient Communication, Strategy, leadership, patient education, social media | Tagged , , | 1 Comment